Literature DB >> 19027064

Nrf2-dependent sulfiredoxin-1 expression protects against cigarette smoke-induced oxidative stress in lungs.

Anju Singh1, Guoyu Ling, Avvaru N Suhasini, Ping Zhang, Masayuki Yamamoto, Ana Navas-Acien, Gregory Cosgrove, Rubin M Tuder, Thomas W Kensler, Walter H Watson, Shyam Biswal.   

Abstract

Oxidative stress results in protein oxidation and is involved in the pathogenesis of lung diseases such as chronic obstructive pulmonary disorder (COPD). Sulfiredoxin-1 (Srx1) catalyzes the reduction of cysteine sulfinic acid to sulfenic acid in oxidized proteins and protects them from inactivation. This study examined the mechanism of transcriptional regulation of Srx1 and its possible protective role during oxidative stress associated with COPD. Nrf2, a transcription factor known to influence susceptibility to pulmonary diseases, upregulates Srx1 expression during oxidative stress caused by cigarette smoke exposure in the lungs of mice. Disruption of Nrf2 signaling by genetic knockout in mice or RNAi in cells downregulated the expression of Srx1. In silico analysis of the 5'-promoter-flanking region of Srx1 identified multiple antioxidant-response elements (AREs) that are highly conserved. Reporter and chromatin-immunoprecipitation assays demonstrated that ARE1 at -228 is critical for the Nrf2-mediated response. Attenuation of Srx1 expression with RNAi potentiated the toxicity of hydrogen peroxide (H2O2), whereas overexpression of Srx1 protected against H2O2-mediated cell death in vitro. Immunoblot analysis revealed dramatic decreases in Srx1 expression in lungs from patients with COPD relative to nonemphysematous lungs together with a decline in Nrf2 protein. Thus, Srx1, a key Nrf2-regulated gene, contributes to protection against oxidative injury in the lung.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19027064      PMCID: PMC2828157          DOI: 10.1016/j.freeradbiomed.2008.10.026

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  53 in total

1.  A cysteine-sulfinic acid in peroxiredoxin regulates H2O2-sensing by the antioxidant Pap1 pathway.

Authors:  Ana P Vivancos; Esther A Castillo; Benoît Biteau; Carine Nicot; José Ayté; Michel B Toledano; Elena Hidalgo
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-13       Impact factor: 11.205

2.  Chronic obstructive pulmonary disease: current burden and future projections.

Authors:  A D Lopez; K Shibuya; C Rao; C D Mathers; A L Hansell; L S Held; V Schmid; S Buist
Journal:  Eur Respir J       Date:  2006-02       Impact factor: 16.671

3.  Glutathione peroxidase 2, the major cigarette smoke-inducible isoform of GPX in lungs, is regulated by Nrf2.

Authors:  Anju Singh; Tirumalai Rangasamy; Rajesh K Thimmulappa; Hannah Lee; William O Osburn; Regina Brigelius-Flohé; Thomas W Kensler; Masayuki Yamamoto; Shyam Biswal
Journal:  Am J Respir Cell Mol Biol       Date:  2006-06-22       Impact factor: 6.914

4.  A novel role for human sulfiredoxin in the reversal of glutathionylation.

Authors:  Victoria J Findlay; Danyelle M Townsend; Taylor E Morris; Jacob P Fraser; Lin He; Kenneth D Tew
Journal:  Cancer Res       Date:  2006-07-01       Impact factor: 12.701

5.  The consensus coding sequences of human breast and colorectal cancers.

Authors:  Tobias Sjöblom; Siân Jones; Laura D Wood; D Williams Parsons; Jimmy Lin; Thomas D Barber; Diana Mandelker; Rebecca J Leary; Janine Ptak; Natalie Silliman; Steve Szabo; Phillip Buckhaults; Christopher Farrell; Paul Meeh; Sanford D Markowitz; Joseph Willis; Dawn Dawson; James K V Willson; Adi F Gazdar; James Hartigan; Leo Wu; Changsheng Liu; Giovanni Parmigiani; Ben Ho Park; Kurtis E Bachman; Nickolas Papadopoulos; Bert Vogelstein; Kenneth W Kinzler; Victor E Velculescu
Journal:  Science       Date:  2006-09-07       Impact factor: 47.728

Review 6.  Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy.

Authors:  Paul Kirkham; Irfan Rahman
Journal:  Pharmacol Ther       Date:  2006-02-03       Impact factor: 12.310

7.  Nrf2-dependent protection from LPS induced inflammatory response and mortality by CDDO-Imidazolide.

Authors:  Rajesh K Thimmulappa; Catherine Scollick; Kassim Traore; Melinda Yates; Michael A Trush; Karen T Liby; Michael B Sporn; Masayuki Yamamoto; Thomas W Kensler; Shyam Biswal
Journal:  Biochem Biophys Res Commun       Date:  2006-10-30       Impact factor: 3.575

8.  Global gene expression associated with hepatocarcinogenesis in adult male mice induced by in utero arsenic exposure.

Authors:  Jie Liu; Yaxiong Xie; Danica M K Ducharme; Jun Shen; Bhalchandra A Diwan; B Alex Merrick; Sherry F Grissom; Charles J Tucker; Richard S Paules; Raymond Tennant; Michael P Waalkes
Journal:  Environ Health Perspect       Date:  2006-03       Impact factor: 9.031

9.  Modulation of glutaredoxin in the lung and sputum of cigarette smokers and chronic obstructive pulmonary disease.

Authors:  Mirva J Peltoniemi; Paula H Rytilä; Terttu H Harju; Ylermi M Soini; Kaisa M Salmenkivi; Lloyd W Ruddock; Vuokko L Kinnula
Journal:  Respir Res       Date:  2006-10-25

10.  Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice.

Authors:  Tirumalai Rangasamy; Jia Guo; Wayne A Mitzner; Jessica Roman; Anju Singh; Allison D Fryer; Masayuki Yamamoto; Thomas W Kensler; Rubin M Tuder; Steve N Georas; Shyam Biswal
Journal:  J Exp Med       Date:  2005-07-04       Impact factor: 14.307

View more
  57 in total

1.  The curcuminoid CLEFMA selectively induces cell death in H441 lung adenocarcinoma cells via oxidative stress.

Authors:  Kaustuv Sahoo; Mikhail G Dozmorov; Shrikant Anant; Vibhudutta Awasthi
Journal:  Invest New Drugs       Date:  2010-12-22       Impact factor: 3.850

2.  Denitrosylation of HDAC2 by targeting Nrf2 restores glucocorticosteroid sensitivity in macrophages from COPD patients.

Authors:  Deepti Malhotra; Rajesh K Thimmulappa; Nicolas Mercado; Kazuhiro Ito; Ponvijay Kombairaju; Sarvesh Kumar; Jinfang Ma; David Feller-Kopman; Robert Wise; Peter Barnes; Shyam Biswal
Journal:  J Clin Invest       Date:  2011-10-17       Impact factor: 14.808

Review 3.  Mitochondrial thiols in the regulation of cell death pathways.

Authors:  Fei Yin; Harsh Sancheti; Enrique Cadenas
Journal:  Antioxid Redox Signal       Date:  2012-06-11       Impact factor: 8.401

4.  Targeting Nrf2 signaling improves bacterial clearance by alveolar macrophages in patients with COPD and in a mouse model.

Authors:  Christopher J Harvey; Rajesh K Thimmulappa; Sanjay Sethi; Xiaoni Kong; Lonny Yarmus; Robert H Brown; David Feller-Kopman; Robert Wise; Shyam Biswal
Journal:  Sci Transl Med       Date:  2011-04-13       Impact factor: 17.956

5.  Long-Term Cigarette Smoke Exposure and Changes in MiRNA Expression and Proteome in Non-Small-Cell Lung Cancer.

Authors:  Jayshree Advani; Yashwanth Subbannayya; Krishna Patel; Aafaque Ahmad Khan; Arun H Patil; Ankit P Jain; Hitendra S Solanki; Aneesha Radhakrishnan; Sneha M Pinto; Nandini A Sahasrabuddhe; Joji K Thomas; Premendu P Mathur; Bipin G Nair; Xiaofei Chang; T S Keshava Prasad; David Sidransky; Harsha Gowda; Aditi Chatterjee
Journal:  OMICS       Date:  2017-07

6.  Nrf2-activated expression of sulfiredoxin contributes to urethane-induced lung tumorigenesis.

Authors:  Murli Mishra; Hong Jiang; Hedy A Chawsheen; Matthieu Gerard; Michel B Toledano; Qiou Wei
Journal:  Cancer Lett       Date:  2018-06-15       Impact factor: 8.679

7.  Ectodermal-neural cortex 1 down-regulates Nrf2 at the translational level.

Authors:  Xiao-Jun Wang; Donna D Zhang
Journal:  PLoS One       Date:  2009-05-08       Impact factor: 3.240

8.  Luteolin triggers global changes in the microglial transcriptome leading to a unique anti-inflammatory and neuroprotective phenotype.

Authors:  Konstantin Dirscherl; Marcus Karlstetter; Stefanie Ebert; Dominik Kraus; Julia Hlawatsch; Yana Walczak; Christoph Moehle; Rudolf Fuchshofer; Thomas Langmann
Journal:  J Neuroinflammation       Date:  2010-01-14       Impact factor: 8.322

9.  Cytoprotective Nrf2 pathway is induced in chronically txnrd 1-deficient hepatocytes.

Authors:  Elena S Suvorova; Olivier Lucas; Carla M Weisend; Maryclare F Rollins; Gary F Merrill; Mario R Capecchi; Edward E Schmidt
Journal:  PLoS One       Date:  2009-07-07       Impact factor: 3.240

10.  Transcriptome profiles of carcinoma-in-situ and invasive non-small cell lung cancer as revealed by SAGE.

Authors:  Kim M Lonergan; Raj Chari; Bradley P Coe; Ian M Wilson; Ming-Sound Tsao; Raymond T Ng; Calum Macaulay; Stephen Lam; Wan L Lam
Journal:  PLoS One       Date:  2010-02-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.